In a global first in Uganda today, @MinofHealthUG, WHO, and other partners launched a first-ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency. The principal investigators from @Makerere University and the Uganda Virus Research Institute (@UVRIug), with support from WHO and other partners, have worked tirelessly to get the trial ready in 4 days since the outbreak was confirmed on 30 January. The speed was achieved through advanced research preparedness while ensuring full compliance with national and international regulatory and ethical requirements. The candidate vaccine was donated by IAVI, with financial support from WHO, the Coalition for Epidemic Preparedness Innovations (@CEPIvaccines), Canada’s International Development Research Centre (@IDRC_CRDI), and the European Commission's Health Emergency Preparedness and Response Authority (@EC_HERA) and support from the Africa Centres for Disease Control and Prevention (@AfricaCDC). Press release: bit.ly/3WLdFy1